We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The CMA is investigating Microsoft Corporation’s (Microsoft) hiring of certain former employees of Inflection AI, Inc. (Inflection AI) and its entry into associated arrangements with Inflection AI.
The CMA has won an important legal challenge in the High Court after the CAT refused to grant it a domestic search warrant as part of a cartel investigation.
The CMA has outlined 3 key risks to effective competition on AI Foundation Models and has set out plans for further action in the market.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Information about how the Competition and Markets Authority responded to the coronavirus (COVID-19) outbreak.
All data on external disclosures made to the CMA
This collection brings together all the Competition and Markets Authority's (CMA) board meeting minutes.
The CMA is reviewing Part 3, Article 29, and Part 1 of Schedule 4 of the Home Credit Market Investigation Order 2007
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Letters sent by the Competition and Markets Authority (CMA) to companies about their non-compliance with market investigation orders and undertakings.
Tell the CMA about issues with a business, a market, or to provide information about a new or existing case.
Documents relating to workforce management information summary data for the Competition and Markets Authority.
Information about what to do if you receive a warning or advisory letter from the CMA.
Information about the CMA’s review of the PCR Testing Market.
The CMA has published its response to DESNZ’s consultation on an open data scheme and ongoing monitoring function for road fuel prices.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Tell the CMA about competition and consumer issues.
Karen Croxson joined the CMA in September 2023 and was appointed as its first Chief Data, Technology and Insight Officer on 2 April 2024. Karen is a member of the Senior Executive Team and oversees all the CMA’s work related...
The CMA has published its response to the Office for Zero Emission Vehicles’ (OZEV) consultation on the rapid charging fund (RCF).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.